Health product recall

Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

Last updated

Summary

Product
Accel-Ondansetron ODT 4 & 8 mg
Issue
Health products - Product quality
What to do

Return the affected products to your local pharmacy for a replacement, and for proper disposal. If you are unsure whether your product is affected, check with your pharmacy. Consult a health care professional if you have used the affected product and you have health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

Accel-Ondansetron ODT 4 mg

Accel-Ondansetron ODT 4 mg

DIN 02535319

Tablet (Orally Disintegrating)

Ondansetron 4 mg

CDX00123

Accel-Ondansetron ODT 8 mg

Accel-Ondansetron ODT 8 mg

DIN 02535327

Tablet (Orally Disintegrating)

Ondansetron 8 mg

CEA00123

Issue

Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

What you should do

  • Return the affected products to your local pharmacy for a replacement, and for proper disposal. If you are unsure whether your product is affected, check with your pharmacy.
  • Consult a health care professional if you have used the affected product and you have health concerns.
  • Report any health product-related side effects or complaints to Health Canada.
  • Contact the companies if you have questions about their recall:
    • Accel Pharma Inc., by contacting Betty Cory at Accel Quality Assurance by calling 416-271-4775, or by email at bcory@regxia.com
    • Mint Pharmaceuticals Inc., by contacting Olenka Crewe at Mint Pharmaceuticals Inc. Scientific Affairs by calling 416-803-9151, or by email at olenkac@mintpharmaceuticals.com
    • Pharmascience Inc. by calling, toll-free, at 1-800-340-9735, or by email at customercarePms@pharmascience.com

Additional information

Previous recalls or alerts
Background

Depth of recall: Retailers, Healthcare Establishments

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Accel Pharma Inc.

119 Labrosse Ave, Pointe-Claire

QC, H9R 1A3

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-75630

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe